Back to Results
First PageMeta Content
Pharmacology / Organofluorides / GlaxoSmithKline / Respiratory therapy / Autoimmune diseases / Topical steroid / Corticosteroid / Fluticasone propionate / Eczema / Medicine / Pulmonology / Glucocorticoids


NDA[removed]S-011 Page 1 PRODUCT INFORMATION CUTIVATE
Add to Reading List

Document Date: 2004-09-14 08:01:30

Open Document

File Size: 63,03 KB

Share Result on Facebook

City

Triangle Park / /

Company

GlaxoSmithKline / Ames / /

Country

United States / /

Currency

pence / /

Event

FDA Phase / /

Facility

Laboratory Tests / /

IndustryTerm

topical products / potent topical corticosteroid products / renal clearance accounting / treatment site / /

MedicalCondition

intracranial hypertension / inflammatory and pruritic manifestations / Allergic contact dermatitis / rosacea and perioral dermatitis / concomitant skin infections / headaches / chronic plaque psoriasis / atopic dermatitis / Telangiectasia / disease / Cushing's syndrome / hives / Carcinogenesis / hyperglycemia / folliculitis / hypopigmentation / acneiform eruptions / erythema / secondary infection / bilateral papilledema / cleft palate / corticosteroid-responsive dermatoses / miliaria / disorder / perioral dermatitis / psoriasis / pustular psoriasis / hypersensitivity / hypertrichosis / irritation / infection / inflammation / pruritus / depression / atopic eczema / syndrome / lightheadedness / human hepatoma cells / /

Organization

DOSAGE AND ADMINISTRATION / /

Person

Jonathan Wilkin / /

Position

physician / General / /

Product

fluticasone propionate / cosyntropin / CUTIVATE / ACTH / S-011 / /

ProvinceOrState

North Carolina / /

Technology

Pharmacokinetics / /

SocialTag